OSR Health (OSRHW) Return on Sales (2024 - 2026)

OSR Health has reported Return on Sales for 3 years, with the latest figure at 0.07% in Q1 2026.

• Quarterly Return on Sales rose 8.0% year-over-year to 0.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.07% (down 2.0% YoY) and the FY2025 annual result came in at 0.09%, down 6.0% from the prior year.
• Return on Sales improved to 0.07% in Q1 2026 per OSRHW's latest filing, from 0.19% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q4 2024 and troughed at 0.19% in Q4 2025.
• A 3-year average of 0.07% and a median of 0.05% in 2025 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2025 and 2026: Return on Sales fell 18 bps in 2025, then grew 8 bps in 2026.
• Over 3 years, Return on Sales stood at 0.01% in 2024, then sank by 1198 bps to 0.19% in 2025, then soared by 62 bps to 0.07% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.07%, 0.19%, and 0.05% for Q1 2026, Q4 2025, and Q3 2025 respectively.